Your browser doesn't support javascript.
loading
Emergence of Neisseria gonorrhoeae Strains Harboring a Novel Combination of Azithromycin-Attenuating Mutations.
Pham, Cau D; Sharpe, Samera; Schlanger, Karen; St Cyr, Sancta; Holderman, Justin; Steece, Richard; Soge, Olusegun O; Masinde, Godfred; Arno, Janet; Schmerer, Matthew; Kersh, Ellen N.
Affiliation
  • Pham CD; Centers for Disease Control and Prevention, Atlanta, Georgia, USA whi4@cdc.gov.
  • Sharpe S; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Schlanger K; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • St Cyr S; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Holderman J; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Steece R; Indiana State Department of Health, Indianapolis, Indiana, USA.
  • Soge OO; Tennessee Department of Health, Nashville, Tennessee, USA.
  • Masinde G; University of Washington, Seattle, Washington, USA.
  • Arno J; San Francisco Department of Public Health, San Francisco, California, USA.
  • Schmerer M; Marion County Public Health Department, Indianapolis, Indiana, USA.
  • Kersh EN; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Article in En | MEDLINE | ID: mdl-30917979
ABSTRACT
The nimbleness of Neisseria gonorrhoeae to evade the effect of antibiotics has perpetuated the fight against antibiotic-resistant gonorrhea for more than 80 years. The ability to develop resistance to antibiotics is attributable to its indiscriminate nature in accepting and integrating exogenous DNA into its genome. Here, we provide data demonstrating a novel combination of the 23S rRNA A2059G mutation with a mosaic-multiple transferable resistance (mosaic-mtr) locus haplotype in 14 N. gonorrhoeae isolates with high-level azithromycin MICs (≥256 µg/ml), a combination that may confer more fitness than in previously identified isolates with high-level azithromycin resistance. To our knowledge, this is the first description of N. gonorrhoeae strains harboring this novel combination of resistance determinants. These strains were isolated at two independent jurisdictions participating in the Gonococcal Isolate Surveillance Project (GISP) and in the Strengthening the U.S. Response to Resistant Gonorrhea (SURRG) project. The data suggest that the genome of N. gonorrhoeae continues to shuffle its genetic material. These findings further illuminate the genomic plasticity of N. gonorrhoeae, which allows this pathogen to develop mutations to escape the inhibitory effects of antibiotics.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azithromycin / Anti-Bacterial Agents / Mutation / Neisseria gonorrhoeae Type of study: Prognostic_studies Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2019 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azithromycin / Anti-Bacterial Agents / Mutation / Neisseria gonorrhoeae Type of study: Prognostic_studies Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2019 Document type: Article Affiliation country: United States